Corner Therapeutics
Watertown, Massachusetts, United States · Biotechnology, Health Care, research
Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust and durable immunity. Corner seeks to transform standard of care, ushering in a new era of robust,
Key facts
- Headquarters
- Watertown, Massachusetts, United States
- Employees
- 35
- Industries
- Biotechnology, Health Care, research
- Status
- Private
- Website
- cornertx.com
- Company page
Recent activity at Corner Therapeutics
Corner Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Venture | $16.8M |
| Aug 2025 | Venture | $58.5M |
| Apr 2025 | Venture | $53.4M |
| Apr 2024 | Venture | $58.5M |
| Apr 2024 | Series A | $54.0M |
Leadership
- Cristina Harris, Associate Director of Human Resources & Business Administration
- Nicholas Seaver, Chief Financial Officer, Chief Business Officer
- Andrew Cornforth, Chief Technology Officer
- Steven Altschuler, Chief Executive Officer
Verified email and direct lines for Corner Therapeutics’s decision-makers are on Fundz. See plans
Employee benefit plans
Corner Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Corner Therapeutics in the news
Companies similar to Corner Therapeutics
- Aptose Biosciences · Biotechnology, Health Care, research, Therapeutics
- Draig Therapeutics · Biotechnology, Health Care, research, Therapeutics
- BioLineRx Ltd · Biotechnology, Health Care, research, Therapeutics
- Brainstorm Cell Therapeutics · Biotechnology, Health Care, research, Therapeutics
- Nuvig Therapeutics · Biotechnology, Health Care, research, Therapeutics
About Corner Therapeutics: questions and answers
What does Corner Therapeutics do?
Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust and durable immunity. Corner seeks to transform standard of care, ushering in a new era of robust,
Where is Corner Therapeutics headquartered?
Corner Therapeutics is headquartered in Watertown, Massachusetts, United States.
How many employees does Corner Therapeutics have?
Corner Therapeutics has about 35 employees.
Has Corner Therapeutics raised funding?
Yes. Fundz has recorded 5 funding events for Corner Therapeutics. The most recent, $16.8M, was in Oct 2025.
Who leads Corner Therapeutics?
Steven Altschuler is a Chief Executive Officer at Corner Therapeutics.
What is the latest news on Corner Therapeutics?
On Oct 20, 2025, Corner Therapeutics
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy